How Clinicians Manage Sleep During Inpatient Hospitalization Following Pediatric Hematopoietic Stem Cell Transplantation

Although pediatric hematopoietic stem cell transplantation (HSCT) patients often experience sleep disruptions during hospitalization, no clinical guidelines exist for how to manage their sleep. We sought to learn how clinicians approach inpatient sleep disruptions by surveying 111 pediatric HSCT medical prescribers, nurses, and psychosocial staff from across the United States. Clinicians estimated 58% of inpatients developed sleep issues. Although they rated external factors (e.g., noise) as most impactful, clinicians were most likely to implement patient-level interventions (e.g., melatonin). Research is needed to assess the efficacy of commonly delivered treatments, as well as to develop and implement systems-level changes addressing external sleep barriers.